levetiracetam

Generic: levetiracetam

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler aurobindo pharma limited
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

levetiracetam 100 mg/mL

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-250
Product ID 65862-250_8cd74ce7-ea18-456e-bc82-34b643055e56
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079063
Listing Expiration 2026-12-31
Marketing Start 2009-01-15

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862250
Hyphenated Format 65862-250

Supplemental Identifiers

RxCUI
403884
UPC
0365862250476
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA079063 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 500 mL in 1 BOTTLE, PLASTIC (65862-250-05)
  • 473 mL in 1 BOTTLE, PLASTIC (65862-250-47)
source: ndc

Packages (2)

65862-250-05 500 mL in 1 BOTTLE, PLASTIC (65862-250-05) 65862-250-47 473 mL in 1 BOTTLE, PLASTIC (65862-250-47)

Ingredients (1)

levetiracetam (100 mg/mL)

Linked Drug Pages (1)

Levetiracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8cd74ce7-ea18-456e-bc82-34b643055e56", "openfda": {"nui": ["N0000008486"], "upc": ["0365862250476"], "unii": ["44YRR34555"], "rxcui": ["403884"], "spl_set_id": ["f65ec19d-b90e-452e-b761-c68b1cf2c892"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 mL in 1 BOTTLE, PLASTIC (65862-250-05)", "package_ndc": "65862-250-05", "marketing_start_date": "20090115"}, {"sample": false, "description": "473 mL in 1 BOTTLE, PLASTIC (65862-250-47)", "package_ndc": "65862-250-47", "marketing_start_date": "20090115"}], "brand_name": "Levetiracetam", "product_id": "65862-250_8cd74ce7-ea18-456e-bc82-34b643055e56", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "65862-250", "generic_name": "Levetiracetam", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "100 mg/mL"}], "application_number": "ANDA079063", "marketing_category": "ANDA", "marketing_start_date": "20090115", "listing_expiration_date": "20261231"}